Clinical Outcomes of People Who Acquired HIV in Early Life
Clinical Outcomes in Persons With HIV Acquired Early in Life
2 other identifiers
observational
177
1 country
1
Brief Summary
Background: \- Long-term survival with the human immunodeficiency virus (HIV) is not well understood. Adults who were infected with HIV as children have lived with the virus for many years. However, the effect of HIV on this group of people has not been studied in depth. Researchers are interested in studying how HIV infection and the medicines used to treat it affect people who were infected early in life. They want to find out if there are any problems with how HIV-infected children grow and develop as adults, especially if they have developed heart problems. As part of this study, people with HIV will be compared with healthy volunteers. Objectives: \- To study the effect of HIV infection and treatment on people who acquired HIV infection in early life. Eligibility:
- Individuals at least 18 years of age who acquired HIV infection in early life.
- Healthy volunteers at least 18 years of age without HIV will serve as controls Design:
- Participants will be screened with a physical exam and medical history. They will have regular study visits about once a year for up to 10 years to collect health information.
- Blood and urine samples will be collected to look at kidney and liver function.
- X-ray scans will be used to look at bone density and the amount of fat and muscle in the body.
- Treatment will not be provided as part of this study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 31, 2012
CompletedFirst Posted
Study publicly available on registry
August 3, 2012
CompletedStudy Start
First participant enrolled
August 27, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 8, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 8, 2023
CompletedMarch 9, 2023
March 1, 2023
10.5 years
July 31, 2012
March 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Health Status
vital status and health outcomes will be determined annually throughout the study
End of Study
Study Arms (3)
Healthy Controls
Individuals with no known history of HIV
Healthy Controls - Questionnaire Group
Individuals with no known history of HIV
HIV
Individuals who acquired HIV in early life
Eligibility Criteria
HIV infected young adults; Healthy volunteers
You may qualify if:
- HIV positive participants
- Known HIV infection, confirmed by laboratory testing and documented or believed to have been acquired during the first decade of life
- Age greater than or equal to 18 years
- HIV negative controls
- HIV negative, documented by a negative ELISA
- Age greater than or equal to 18 years
- Free of any major underlying medical disorder
- Not currently pregnant
- For Reproductive Health Sub-Study:
- HIV positive participants
- Known HIV infection, confirmed by laboratory testing and documented or believed to have been acquired during the first decade of life
- Age greater than or equal to 18 years
- Capable of providing independent informed consent
- HIV negative controls
- HIV negative, verified by a negative ELISA
- +4 more criteria
You may not qualify if:
- Clinically significant condition or systemic illness (serious infections or significant cardiac, pulmonary, hepatic or other organ dysfunction) which in the judgment of the Principal Investigator would compromise the patient s ability to tolerate this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Related Publications (6)
Aepfelbacher JA, Chaudhury CS, Mee T, Purdy JB, Hawkins K, Curl KA, Dee N, Hadigan C. Reproductive and sexual health knowledge, experiences, and milestones in young adults with life-long HIV. AIDS Care. 2020 Mar;32(3):354-361. doi: 10.1080/09540121.2019.1679711. Epub 2019 Oct 22.
PMID: 31640401BACKGROUNDAbd-Elmoniem KZ, Ishaq H, Purdy J, Matta J, Hamimi A, Hannoush H, Hadigan C, Gharib AM. Association of Coronary Wall Thickening and Diminished Diastolic Function in Asymptomatic, Low Cardiovascular Disease-Risk Persons Living with HIV. Radiol Cardiothorac Imaging. 2024 Apr;6(2):e230102. doi: 10.1148/ryct.230102.
PMID: 38573125DERIVEDSahagun SJ, Yeramosu T, Purdy JB, Reynolds JC, Hadigan CM. Associations Between Central Obesity and Lifelong Antiviral Therapy in Adults Living With HIV Acquired From Early Childhood. J Acquir Immune Defic Syndr. 2022 Feb 1;89(2):208-214. doi: 10.1097/QAI.0000000000002841.
PMID: 34693931DERIVEDAepfelbacher JA, Balmaceda J, Purdy J, Mattingly A, Zambell K, Hawkins K, Chairez C, Curl KA, Dee N, Hadigan C. Increased Prevalence of Hepatic Steatosis in Young Adults With Lifelong HIV. J Infect Dis. 2019 Jun 19;220(2):266-269. doi: 10.1093/infdis/jiz096.
PMID: 30852587DERIVEDUnsal AB, Mattingly AS, Jones SE, Purdy JB, Reynolds JC, Kopp JB, Hazra R, Hadigan CM. Effect of Antiretroviral Therapy on Bone and Renal Health in Young Adults Infected With HIV in Early Life. J Clin Endocrinol Metab. 2017 Aug 1;102(8):2896-2904. doi: 10.1210/jc.2017-00197.
PMID: 28531309DERIVEDMattingly AS, Unsal AB, Purdy JB, Gharib AM, Rupert A, Kovacs JA, McAreavey D, Hazra R, Abd-Elmoniem KZ, Hadigan C. T-cell Activation and E-selectin Are Associated With Coronary Plaque in HIV-infected Young Adults. Pediatr Infect Dis J. 2017 Jan;36(1):63-65. doi: 10.1097/INF.0000000000001354.
PMID: 27749650DERIVED
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Colleen M Hadigan, M.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 31, 2012
First Posted
August 3, 2012
Study Start
August 27, 2012
Primary Completion
March 8, 2023
Study Completion
March 8, 2023
Last Updated
March 9, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share
.This is not an interventional study. This is a natural history study. Results are provided in aggregate in the form of published journal articles.